Research led by King’s scientists, and published online in the journal Nature, sheds new light on the development of the immune cells which are critical in fighting infection and some tumours. It may also provide clues to the mystery of why autoimmune diseases in women often go into remission during pregnancy.
A team of researchers, led by scientists at Dartmouth Medical School and Dartmouth College, have identified and tested a gene that dramatically alters both muscle metabolism and performance. The researchers say that this finding could someday lead to treatment for muscle diseases, including helping the elderly who suffer from muscle deterioration and improving muscle performance in endurance athletes.
Another late-breaker presented here was the appropriately named CHICAGO Study, in which 462 patients with type 2 diabetes were randomly selected at Chicago heart clinics to receive treatment with pioglitazone or with glimepriride.
For two consecutive years, researchers examined measures of cardiovascular fitness and self-esteem in sophomore girls attending Trenton Central High School and found students are making better health choices with an intervention program. Low Density Lipoprotein levels — the unhealthy cholesterol — also decreased significantly. WHF Teen Esteem is a gender-specific approach to teen girls’ health and wellness and is meant to be a replacement for traditional gymnastics and health classes.
For two consecutive years, researchers examined measures of cardiovascular fitness and self-esteem in sophomore girls attending Trenton Central High School and found students are making better health choices with an intervention program. Low Density Lipoprotein levels — the unhealthy cholesterol — also decreased significantly. WHF Teen Esteem is a gender-specific approach to teen girls’ health and wellness and is meant to be a replacement for traditional gymnastics and health classes.
A drug commonly used to increase the body’s sensitivity to insulin may slow the progression of cardiovascular disease in patients with type 2 diabetes, according to a study at the University of Illinois at Chicago College of Medicine.
A medication given to diabetics to improve their body’s sensitivity to insulin also appears to slow the thickening of their artery walls, according to a study posted online today by JAMA. The study is being released early to coincide with its presentation at the American Heart Association Scientific Session. It will be published in the December 6 print issue of JAMA.
Scientists at Children?s Hospital of Pittsburgh of UPMC have identified a protein that is critical to the development of inflammation during lung infection in patients with cystic fibrosis (CF). The identification of this protein, called interleukin-23 (IL-23), is an important finding that gives researchers a specific target for developing new therapies.
Abbott and Kos Pharmaceuticals, Inc. today announced a definitive agreement for Abbott to acquire Kos for $78 per share in cash, for a total transaction value of $3.7 billion, net of cash currently held by Kos. Based in Cranbury, N.J., Kos is a specialty pharmaceutical company that develops and markets proprietary medications for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company has a growing presence in the $20 billion lipid management market.
The high consumption of sweetened food and drink increases the risk of developing pancreatic cancer, according to a new study from Karolinska Institutet. A heavy intake of fizzy drinks, creamed fruit and sugar in coffee are three common ways of increasing the risk.